# 3. Neurological Trauma

Educational materials and pathways regarding the evaluation and management of neurological injuries.

# Cervical Spine Evaluation and Management

### **Cervical Spine Evaluation and Management**

**Purpose:** Although cervical spine injuries are relatively uncommon among all trauma patients presenting to emergency departments (approximately 1-3%), cervical spine fractures and associated spinal cord or blunt cerebrovascular injuries can be potentially devastating to an individual. These guidelines serve to provide our trauma patients with an efficient and thorough evaluation of the cervical spine with either clearance of c-spine precautions or appropriate intervention and treatment of injuries when identified.

#### **C-spine Precautions:**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>I.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Who needs C-spine precautions?

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>All blunt trauma patients should be placed in c-spine precautions until the cervical spine can be appropriately evaluated and cleared.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Penetrating trauma patients do not need to be placed in c-spine precautions unless there is other associated blunt trauma or they are unevaluable and blunt force trauma cannot be excluded.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>II.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-family: Times New Roman; font-size: xx-small;">“</span>C-spine precautions” includes:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Bedrest (until remainder of spine can be cleared/evaluated)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Head flat (in a neutral position)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">c.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>C-spine immobilization in a rigid cervical collar (Philadelphia collar or Miami-J) at all times

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">d.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Transport flat or in reverse Trendelenburg on a gurney

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>III.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In low risk patients, after T&amp;L spines have been cleared, the Trauma Attending or Fellow may use his/her judgement and write the c-spine precautions order to include “HOB may be 30 degrees up.”

#### **C-Spine Evaluation and Clearance of Cervical Collar:**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>I.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Routine c-spine clearance includes imaging of the cervical spine COMBINED WITH a clinical exam of the cervical spine.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**A CT c-spine is the preferred imaging modality** for evaluation of the cervical spine if the patient is scheduled to undergo another type of CT examination.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>If cervical spine x-rays are obtained, they must be considered adequate films which allow complete visualization of all cervical vertebra (from the skull base down to T1).

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">c.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">NEXUS CRITERIA--In patients that are a GCS 15, examinable and no further CT scans are planned, the c-collar can be cleared clinically using the National Emergency X-Radiography Utilization Study (NEXUS) criteria without additional c-spine imaging. </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">NEXUS low-risk criteria include:</span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">No posterior midline cervical-spine tenderness</span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">No evidence of intoxication </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">A normal level of alertness</span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">No focal neurologic deficit </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">No painful distracting injuries </span>

<span style="color: black; mso-themecolor: text1;">If ALL of these criteria are met, no additional imaging is required and the c-collar may be cleared with clinical exam alone. If any of these criteria are not met, one should proceed with CT c-spine to further evaluate for cervical spine injury. </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">d.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">Special populations:</span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">Pediatric patients (15 and younger)</span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">If the child is awake/alert and examinable, the cervical spine should be attempted to be cleared with NEXUS Criteria. </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">If the child is obtaining CT scans for work-up of other injuries, obtain a CT c-spine. </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">Elderly patients (age 65 yrs and older)</span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">Elderly patients are more likely to have cervical spine injury without associated mid-line tenderness. In patients 65 years or older, have a lower threshold to obtain CT c-spine depending on the mechanism of injury. </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>II.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**Patients with any spinal fracture should have a radiologic exam of the entire spine**.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>III.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>C-spine clearance after negative imaging tests

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Clinically clearing the c-spine involves performing a physical examination to rule out midline pain or tenderness with palpation and range of motion (ROM).

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>First, palpate the cervical spine down the midline. <span style="mso-spacerun: yes;"> </span>If the patient denies midline pain and tenderness with palpation, the anterior half of the collar may then be removed.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Next, the patient should then be given clear instructions to slowly move his/her head from side to side (without assistance) and then back to front and to stop at any time if he/she experiences any pain/discomfort. If no midline cervical spine pain is appreciated with ROM, then the c-collar may be removed.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**Both an order and a progress note** (documenting that the patient’s C-spine has been both radiographically and clinically cleared) must be written in order to clarify that the patient no longer requires c-spine precautions.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>IV.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Any patient with:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Midline cervical pain or tenderness

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>A distracting injury or competing pain

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">c.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Intoxication (any intoxicating substance)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">d.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Any head injury or impaired level of consciousness

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">e.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Focal neurologic deficit

 **SHOULD NOT undergo attempted clinical exam/clearance** until sensorium is cleared.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>V.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patients who are obtunded due to injury, intubated for a prolonged period of time or are unable/incapable of having his/her c-spine cleared clinically:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>C-collar maybe cleared based on negative imaging (CT C-spine) alone at the discretion of the trauma attending

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="mso-spacerun: yes;"> </span>consider MRI of the c-spine within the first 72 hours of admission (if clinically stable to do so) to rule out ligamentous injury in patients sustaining poly trauma or injury secondary to high energy mechanisms. If the MRI does not demonstrate signs of ligamentous injury, the C-collar may be removed.

#### **C-spine Injury Present or Unable to Clear C-collar:**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>I.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Any patient with complaints of midline pain or tenderness of the c-spine should be kept in a cervical collar regardless of their radiographic exam results.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>II.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**<u>Negative CT c-spine but persistent pain</u>** on clinical exam. <span style="mso-spacerun: yes;"> </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>A second attempt to clear the cervical collar with exam should be made 12-24 hours following the initial attempt.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>If still unable to clear a patient’s c-spine:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>The patient should be instructed to wear the collar for 2 weeks and follow-up in Spine clinic for repeat evaluation and clearance of precautions. <span style="mso-spacerun: yes;"> </span>This has been approved by Drs. Wilson (Neurosurgery) and Vincent (Ortho Spine).

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Consider MRI c-spine in special populations such as elderly where the presence of a c-collar may result in significant dysphagia or impair balance or mobility. This should be discussed with the trauma attending prior to obtaining.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>III.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Any patient with a **<u>c-spine injury noted on imaging <span style="color: black; mso-themecolor: text1;">or has neurologic deficits present</span></u>**<span style="color: black; mso-themecolor: text1;"> on exam </span>should be maintained in c-spine precautions and receive a formal spine surgery consult (either neurosurgery or orthopedic spine service).

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>If other spine injuries are present, the consulting spine team will be responsible for clearance of the cervical spine.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patients with any cervical or &gt; 3 thoracic/lumbar isolated transverse process or spinous process fractures should receive spine consultation. <span style="mso-spacerun: yes;"> </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>IV.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Some cervical spine fractures are associated with increased risk of blunt cerebrovascular injury (BCVI) and should be investigated with a CTA neck. Risk factors for BCVI are high energy transfer mechanisms associated with:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Displaced mid-face fracture (LeForte II or III)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Basilar skull fracture involving carotid canal

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">c.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Closed head injury consistent with diffuse axonal injury and GCS &lt;6

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">d.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Cervical body fracture or transverse foramen fracture, subluxation or ligamentous injury at any level

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">e.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Cervical fractures, at any level

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">f.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Near hanging with cerebral anoxia

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">g.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Clothesline type injury or seatbelt abrasion (sign) with significant swelling, pain or altered mental status.<span style="color: red;"> </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>V.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patients who require a c-collar for extended periods of time are at risk for skin breakdown and pressure wounds.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Mechanisms to prevent this include:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>exchange the Philadelphia collar to a Miami-J collar

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>ensure collar fits properly and has pads in appropriate locations

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>iii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>consider consulting Hanger or Burton for custom fit cervical collars

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span>iv.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">nursing is performing appropriate c-collar cares daily </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">cervical collar care performed q shift to assess skin for red/opened areas </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">pads should be changed daily and as needed if soiled </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="color: black; mso-themecolor: text1;">if patient is on flat bedrest, consider using ICU occipital back panel with Vista collar to reduce skin breakdown</span>

#### **REFERENCES:**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Grossman MD, Reilly PM, Gillett T, Gillett D. National survey of the incidence of cervical spine injury and approach to cervical spine clearance in U.S. trauma centers. *J Trauma.* 1999; 47(4):684-90.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Hoffman JR, Mower WR, Wolfson AB, Todd KH, Zucker MI. Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma. National Emergency X-Radiography Utilization Group. *N Engl J Med.* 2000; 343(2):94-9.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Inaba K, Byerly S, Bush LD, Martin MJ, Martin DT, Peck KA, et al. Cervical Spinal Clearance: A Prospective Western Trauma Association Multi-Institutional Trial. *J Trauma Acute Care Surg.* 2016; 81(6):1122-30.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Ciesla DJ, Shatz DV, Moore EE, Sava J, Martin M, Brown CVR, Alam HB, Vercruysse G, Brasel K, Inaba K. Western Trauma Association critical decisions in trauma: cervical spine clearance in trauma patients. *J Trauma Acute Care Surg.* 2020;88(2):352-54.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Biffl WL, Cothren CC, Moore EE, Kozar R, Cocanour C, Davis JW, McIntyre RC, Jr., West MA, Moore FA. Western Trauma Association critical decisions in trauma: screening for and treatment of blunt cerebrovascular injuries. *J Trauma.*2009;67(6):1150-3.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patel MB, Humble SS, Cullinane DC, Day MA, et al. Cervical spine collar clearance in the obtunded adult blunt trauma patient: a systematic review and practice management guideline from the Eastern Association for the Surgery of Trauma. *J Trauma Acute Care Surg*<span style="mso-spacerun: yes;"> </span>2015; 78(2):430-441.

# Intracranial Hypertension Management Algorithm

[![ICH mgmt algorithm.jpg](https://paths.trauma.ai/uploads/images/gallery/2023-04/scaled-1680-/ich-mgmt-algorithm.jpg)](https://paths.trauma.ai/uploads/images/gallery/2023-04/ich-mgmt-algorithm.jpg)

# Management of Traumatic Brain Injury

### Management of Traumatic Brain Injury 

This document provides an overview of considerations and guidelines that are important in the evaluation and management of patients with traumatic brain injury (TBI). It is not intended to be used a rigid set of treatment instructions. Management of TBI must be individualized based on each patient’s clinical situation and the clinical judgment of the providers responsible for directing this aspect of patient care.

#### Resuscitation and Basic Physiological Goals

The following physiological parameters should be maintained as part of goal directed TBI treatment:

- **Primary Parameters:**
    - - - - Pulse Ox <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥ 90%</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">PaO2</span> <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥ 100 mmHg</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">PaCO2</span> 35-40 mmHg
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">SBP ≥ 110 mmHg and ≤ 160 mmHg </span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">pH 7.35-7.45</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">ICP &lt; 20 mmHg</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Temp 36.0-38.3⁰C</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Glucose ≤ 160 mg/dL</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">INR ≤ 1.3</span>
                - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Sodium goal </span>
                    - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Normonatremia (Na 135-145 mmol/L) vs permissive hypernatremia (Na 145-155 mmol/L)</span>
- **<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Secondary Parameters</span>**
    - - - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Cerebral Perfusion Pressure (CPP)</span>
                - - Avoid aggressive use of pressors or fluids to maintain CPP <u>&gt; </u>70 mm Hg
                    - Avoid CPP &lt; 60
                    - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Pediatrics: CPP 40-50 mmHg</span>
        - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">PbtO2</span> <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥ 15 mmHg</span>
- <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Required monitoring/measurements in patients with severe TBI requiring mechanical ventilation </span>
    - - Continuous SpO2 and EtCO2 monitors
        - Indwelling urinary catheter to monitor UOP; may consider transition to external catheter after first 24 hrs
        - Arterial catheter with continuous arterial pressure monitoring
        - Hourly neurological exams

##### <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Airway Management

- <u>Patients with a GCS &lt; 8 should be intubated for airway protection </u>
    - Patients with a GCS &lt; 10 should be considered for intubation.
    - Intubation should be performed with in-line cervical spine immobilization.
    - Rapid sequence intubation (RSI) is the preferred method.
    - If clinical scenario allows, a baseline neurological exam should be obtained prior to intubation.<span style="mso-spacerun: yes;"> </span>
- <u>Sedative and analgesic choices should favor short acting agents</u> throughout the initial resuscitation, as temporal assessment of neurological status is critical. In general, the following agents are recommended: 
    - Etomidate – sedation for induction
    - Succinylcholine – paralytic for induction
    - Propofol – maintenance of sedation and prevention of agitation. Propofol should not be used as an induction agent in the case of trauma and is to be discontinued if its use results in persistent hypotension requiring vasopressor agents.
    - Benzodiazepines – (i.e., midazolam or lorazepam) can be utilized as an initial or substitute sedative agent for propofol.
    - Dexmedetomidine (Precedex)—maintenance sedation and analgesia; can also cause hypotension and bradycardia
    - Fentanyl – can be used for PRN and maintenance analgesia as well as provide some sedation effects.

##### <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Oxygenation/Ventilation

- Avoidance of Hypoxia 
    - Efforts should be made to avoid hypoxia at all times as it has been shown in significantly worsen outcomes in TBI patients.
    - Patients with TBI should have a pulse oximetry maintained at **SpO2<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"> ≥ 90%</span>**<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"> and an attempt for **PaO2 ≥ 100 mmHg**.</span>
- <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">Ventilation</span>
    - Hyperventilation should be intensively monitored during the initial resuscitation. 
        - - Target **PaCO2 is 35-40 mmHg**.
            - Prophylactic Hyperventilation is not recommended (PaCO2 <u>&lt; </u>25 mmHg)
            - An ETCO2 monitor and serial ABGs should be used as needed to prevent profound hypocarbia or hypercarbia.
            - Therapeutic hyperventilation may be necessary for brief periods when there is acute neurological deterioration that coincides with a cerebral herniation syndrome or for refractory elevations in ICP (see section on management of intracranial hypertension).

##### <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Blood Pressure, Volume Resuscitation

- Blood Pressure 
    - Systolic blood pressure (SBP) and mean arterial pressure (MAP) readings should be recorded from a functioning arterial line, when present, or from non-invasive blood pressure (NIBP) cuff when arterial line is not present or presumed inaccurate.
    - Strict blood pressure monitoring and control is required in all TBI patients with care taken to avoid hypotension and hypertension. 
        - - Any patient with intra-cranial hypertension must have an arterial line.
            - SBP should be kept between 110 mmHg and 160 mmHg for the first 7 days following injury or until discharge if patient discharged prior to 7 days. 
                - - it should be noted that even one episode of hypotension (SBP&lt;100mmHg) can significantly worsen outcomes in TBI patients.
            - It should be recognized that lower blood pressures can represent a “relative” hypotensive state in TBI patients (especially with elevated ICP)
            - Normal saline, PRBC, and FFP (when needed) should be used as the initial method of maintaining euvolemia to achieve the target blood pressure
            - Use of vasopressors should be considered for treatment of refractory hypotension ONLY AFTER appropriate volume resuscitation has been given.
            - Vasopressors and Inotropes including phenylephrine, norepinephrine, epinephrine, dobutamine, dopamine, and vasopressin should not be used to counteract the hemodynamic effects of propofol, Precedex or other sedating medications.
            - Labetalol or hydralazine as needed should be administered to treat SBP &gt; 160 mmHg during the initial resuscitation phases.
            - If SBP &gt; 160 mmHg is sustained, consider initiation of nicardipine gtt and/or scheduled beta blocker therapy and placement of arterial line, if not already present.
            - Review home medication lists and consider resuming anti-hypertensive medications as clinically indicated.<span style="color: #00b0f0;"> </span>
- Euvolemia 
    - The primary target is euvolemia through resuscitation. In many cases, a bedside point of care ultrasound (POCUS) with evaluation of the IVC and cardiac function can give the clinician a reasonable assessment of volume status.
    - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Avoid use of hypotonic fluids for volume resuscitation and maintenance fluid support.

##### <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Anemia and Coagulopathy<span style="mso-spacerun: yes;"> </span>

- Hematologic and coagulation panels (CBC, PT/INR, PTT, TEG, fibrinogen, anti-Xa levels, platelet mapping) should be followed closely, particularly in patients on anti-coagulation medications or pre-existing bleeding dyscrasias.
- Patients on anti-coagulant or anti-platelet medications or those with bleeding disorders should be reversed/corrected as clinically indicated to correct coagulopathy regardless of need for surgical intervention. Potential interventions include the following: FFP, vitamin K, prothrombin complex concentrate (PCC)/KCentra, platelets, DDAVP, and NOAC specific reversal agents. 
    - - For patients on antiplatelet medications (i.e. aspirin, Plavix, brilinta), 1 unit of platelets may be transfused if requested by Neurosurgery at the discretion of the trauma or surgical ICU attending. Decision to transfuse additional units of platelets should be based on results of TEG or platelet mapping.
- Target coagulation parameters: 
    - - Hb &gt; 7 g/dL
        - Platelet count <span style="color: black; mso-themecolor: text1;">&gt; 100 x 10<sup>3</sup>/uL<span style="mso-spacerun: yes;"> </span>(if clinically feasible) </span>
        - INR <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≤</span> 1.5
        - Fibrinogen &gt; 150 mg/dL
- INR and platelet count should be corrected in anticipation of operative intervention or bedside procedure such as placement of ICP monitor.

##### <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Imaging

- All patients with suspected or at high risk for possible TBI (i.e., LOC, significant mechanism, amnesia to event, use of anticoagulant/antiplatelet medications) must undergo urgent CT head (CTH) during the initial resuscitation barring need for emergent operative intervention for other life-threatening injuries.
- Repeat CT head will also be obtained at a specified time interval, per neurosurgery recommendations. (within 24 hours of presentation and/or with any significant deterioration in patient’s neurologic status). Additional CT scans will be obtained as needed based on patient clinical condition.
- MRI brain scans should be utilized for assessment of ischemic CVA, DAI, tumors/masses or per certain research protocols. MRI brain can also be used to help prognosticate/determine potential for neurologic viability, particularly in patients with persistent vegetative states. Discussion between Neurosurgery, Neurology, and Trauma can help determine timing and value of the MRI.

##### <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Sedation and Analgesia for intubated TBI patients

- Sedation and analgesia agents will be chose and titrated at the discretion of the surgical ICU attending’s discretion 
    - - Propofol – maintenance of sedation and prevention of agitation. Propofol should not be used as an induction agent in the case of trauma and is to be discontinued if its use results in persistent hypotension requiring vasopressor agents.
        - Benzodiazepines – (i.e., midazolam or lorazepam) can be utilized as an initial or substitute sedative agent for propofol.
        - Dexmedetomidine (Precedex)—maintenance sedation and analgesia; can also cause hypotension and bradycardia
        - Fentanyl/Dilaudid – can be used for PRN and maintenance analgesia as well as provide some sedation effects.
- Ideally, initial agents chosen should favor shorter acting agents so that serial neurologic exams can be obtained.
- In general, sedation will be titrated to RASS goal 0 to -2 unless deeper sedation deemed medically necessary by the surgical ICU attending. <span style="mso-spacerun: yes;"> </span>(i.e. intracranial hypertension, post-traumatic seizures, etc.) 
    - - If ICP monitor in place, sedation should be titrated to maintain ICP &lt; 20 mm Hg.

#### Intracranial Pressure (ICP) Monitoring 

- Placement of ICP monitoring should be considered in the following: 
    - - In patients with a salvageable traumatic brain injury (TBI) if the GCS is &lt;/= 8 following the initial resuscitation and the admission CT scan of the brain is abnormal (i.e., hematomas, contusions, edema, herniation or compressed basal cisterns).
        - Patients undergoing emergent surgical procedures (orthopedic interventions, exploratory laparotomy, etc.) in whom a moderate to severe brain injury is suspected (GCS 3-12) to help guide appropriate intraoperative ICP management.
        - Patients with a normal admission CT scan of the brain but have two or more of the following criteria, 
            - - - Age &gt;40 y/o
                    - Unilateral or bilateral motor posturing
                    - Documented episode of hypotension (SBP&lt;90mm Hg)
- ICP monitors may include an intraventricular catheter (EVD) and/or parenchymal monitor (Bolt). 
    - - Patients with suspected increase in intracranial pressure and GCS <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≤</span> 8 should receive an intraventricular catheter (EVD) or parenchymal monitor at the discretion of the treating Neurosurgeon as the clinical situation mandates.
- Ideally, ICP monitor should be placed within the first 12 hours following admission. ICP monitor placement may also occur later in the resuscitation if the patient’s clinical status declines/changes so that ICP monitoring is now warranted.<span style="mso-spacerun: yes;"> </span>
- Relative contraindications to ICP monitor placement: 
    - - The brain injury is not felt to be salvageable/survivable.
        - Coagulopathy (INR&gt;1.3)
        - Patient is awake/GCS <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥</span> 9
        - Mass lesion with mass effect at the site of the ventriculostomy site
        - Patient known to be post-ictal without obvious brain injury
        - Metabolic causes of coma including intoxication without good evidence of head injury
- Removal of the ICP monitor will be at the discretion of the treating neurosurgeon but should be considered when: 
    - - ICP within normal range
        - 48 to 72 hours after interventions for elevated ICP.
- Target parameters: 
    - - ICP &lt; 20 mmHg
        - Cerebral Perfusion Pressure (CCP) <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥</span> 60 mmHg.

#### Treatment of Intracranial Hypertension 

- Intracranial hypertension is defined as sustained elevation in intracranial pressure (ICP) of more than 15 to 20 mmHg sustained for greater than 5 minutes and occurs when the three intracranial components—blood, brain, and cerebrospinal fluid (CSF)—are no longer able to compensate for volume changes occurring within the cranium.
- <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u>Treatment for intracranial hypertension should be initiated when **ICP** </u>**<u><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥</span> 20 mmHg</u>** and is managed with a leveled algorithm with each level representing increasing levels of intensity. Patients should be initiated in Level 1, then staged through Level 3 as indicated. If the treatments in a given level have not sufficiently lowered the ICP within 20 minutes of implementation, then advancements to the next level should be promptly initiated. 
    - - **<span style="text-decoration: underline;">Level 1</span>**
            - **Notify Neurosurgery**
            - **Positioning--** Elevate head of patient’s bed to <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≥</span> 30 degrees or reverse Trendelenburg position if the T/L spine has not been cleared or there is a known fracture precluding the upright position. Maintain head and neck aligned in a midline neutral position and ensure cervical collar is not restrictively tight.<span style="mso-spacerun: yes;"> </span>
            - **Optimize sedation and analgesia** using recommended agents (propofol, fentanyl and versed) in intubated patients.
            - **ICP monitor –** ensure ICP monitor is functioning properly. If EVD in place, lower and/or open to drain CSF to assess patency. If<span style="mso-spacerun: yes;"> </span>parenchymal monitor in place, consider converting to EVD if situation allows.
            - **If the above maneuvers have not resolved the elevated ICP, move to Level 2.**
        - <span style="text-decoration: underline;">**Level 2**</span>
            - **Hyperosmolar agents**
                - - **Hypertonic Saline** – intermittent boluses of 3% saline (250 mL) may be given in the setting of increased ICP and is preferred if the patient has hypotension or is hypovolemic. Serum sodium and osmolality must be assessed every 6 hours and additional doses should be held if the serum sodium exceeds 160 mEq/L or serum osmolality &gt; 360 mOsm/L
                    - **Mannitol** – intermittent boluses of mannitol (0.25-1gm/kg body weight) may also be administered Attention must be placed upon maintaining a euvolemic state as mannitol will induce an osmotic diuresis. The serum sodium and osmolality must also be assessed frequently (every 6 hrs) and additional doses should be held if the serum sodium exceeds 320 mOsm/L. Maintain a serum osm &lt; 320 mOsm/L with a targeted serum Na of &lt; 160 mEq/L.
            - **Neuromuscular paralysis**: pharmacologic paralysis with a continuous infusion of a neuromuscular blocking agent should be considered if the above measures fail to adequately lower the ICP and restore CPP. The infusions should be titrated to maintain at least two twitches (out of a train of 4) using a peripheral nerve stimulator. Adequate sedation must be utilized if pharmacologic paralysis is employed and can be confirmed with BIS monitoring.
            - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**If the above maneuvers have not resolved the elevated ICP, move to Level 3.**
        - <span style="text-decoration: underline;">**Level 3**</span>
            - CTV head should be considered to evaluate for cerebral sinus thrombosis
            - **Decompressive hemi-craniectomy or bilateral craniectomy** should be discussed and performed at neurosurgery attending discretion.
            - **Barbiturate coma** – an induced coma is an option for those patients who have failed to respond to aggressive measures to control malignant ICP including decompressive craniectomy. The use of BIS monitoring or equivalent is needed for assurance of adequate sedation and coma. Side effects include sudden hemodynamic collapse and a high incidence of pneumonia. Appropriate volume resuscitation and hemodynamic monitoring is mandatory. Utilizing vasopressor therapy may be warranted.

#### Adjunctive Medications and Prevention of Complications 

- Antiseizure prophylaxis 
    - - Keppra (levetiracetam) is the preferred anti-seizure medication given its lower side-effect profile, fewer drug interactions, and less need for tight monitoring of serum levels. Phenytoin/Fosphenytoin (Dilantin) also as efficacy in preventing early post-traumatic seizures in patients with TBI. Seizure prophylaxis should be considered for discontinuation after 7 days if no seizure activity occurs. However, a longer duration should be considered with certain injury patterns or in the presences of post-traumatic seizures.

- Stress Ulcer Prophylaxis 
    - - Patients with significant TBI requiring mechanical ventilation as well as those with coagulopathies or a history of peptic ulcer disease should receive stress ulcer prophylaxis with either an H-2 block agent (famotidine) or proton pump inhibitor.

- Deep Venous Thrombosis (DVT) prophylaxis 
    - - All patients with TBI should receive DVT prophylaxis in the form of sequential compression devices upon admission. Chemoprophylaxis (subcutaneous Lovenox or heparin) should be initiated 48 hours following injury/procedure for most intracranial hemorrhages and after craniotomy OR 24 hours following last stable CT head unless specifically requested by the neurosurgical attending. (see guidelines for VTE prophylaxis in trauma patients)

- Early Tracheostomy 
    - - Tracheostomy within 7 days of admission is recommended in ventilator dependent patients to reduce total days of ET intubation. This is performed at the discretion of the trauma and neurosurgery services.

- Nutritional Support 
    - - Nutritional support should be initiated via enteral route within 48 hours post injury. Frequent assessment of residual volumes of gastric nutrition should be performed, as patients with TBI frequently do not tolerate intragastric feeding and are at risk for emesis and aspiration. Efforts should be made to obtain post-pyloric feeding access (i.e. Cortrak) when possible. Consider holding tube feeds if gastric residual volumes &gt;500 ml.

#### Surgical Management of TBI

Surgical interventions for severe TBI will ultimately be performed at the discretion of the neurosurgery attending/service. However, there are certain criteria and situations where surgery should be considered.

- Epidural hematomas 
    - - An epidural hematoma (EDH) of greater than 30 cm<sup>2</sup> should be surgically removed regardless of GCS. Patients with an acute EDH, GCS &lt;9 and anisocoria should undergo emergent EDH evacuation.
        - Continued non-operative management should be considered in posterior EDH of venous origin.
        - EDH of less than 5mm midline shift in patients with GCS &gt;8 and no focal deficit can be closely monitored in an ICU with serial CT scans. Judicious use of narcotics and sedatives is important to minimize drug related alterations in the neurologic exam. Repeat CT head should be obtained within 6 hours if patients are to be managed non-operatively.

- Acute Subdural Hematomas 
    - - Acute subdural hematomas (SDH) with a thickness of greater than 10 mm or 5mm of midline sift on CT scan should be considered for emergent evacuation regardless of GCS. (Clinical judgement should be used in patients with significant underlying atrophy)
        - A SDH less than 10mm thickness and less than 5mm midline shift should be evacuated emergently if the patient has: GCS decrease by 2 points, asymmetric or fixed pupils, or ICP &gt; 20 mmHg.
        - Repeat CT head should be obtained within 24 hours or sooner if there is deterioration in patient’s neurologic status.

- Subarachnoid Hemorrhage 
    - - In general, subarachnoid hemorrhage (SAH) is managed non-operatively. All patients with GCS <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">≤</span> 8 and SAH should have ICP monitoring with an EVD as the preferred monitoring of choice.
        - Repeat CT head should be obtained within 24 hours or sooner if there is deterioration in patient’s neurologic status.

- Parenchymal lesions 
    - - Intraparenchymal hemorrhage (IPH) causing progressive neurological deterioration, medically refractory ICP elevations, or significant mass effect should be considered for emergent evacuation.
        - Frontal or temporal contusions with IPH &gt; 3cm<sup>3</sup> and &gt;5 mm shift or cistern compression in patients with GCS &lt; 8 should be considered for surgical evacuation.
        - Normal ICP should not preclude operative.
        - Repeat CT head should be obtained within 24 hours or sooner if there is deterioration in patient’s neurologic status.

- Diffuse Medically Refractory Cerebral Edema and Intracranial Hypertension 
    - - Decompressive craniectomy (unilateral or bilateral) within 48 hours of injury should be considered for patients with elevated ICP (&gt;20) refractory to medical management.
        - Ultra-early decompressive craniectomy prior to ICP monitoring is not recommended unless surgery is performed for a mass occupying lesion (hematoma) and the bone flap is not replaced.

- Depressed Skull Fractures 
    - - <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Open skull fractures depressed greater than the thickness of the inner and outer table should be considered for surgical management.
        - Referable symptoms attributed to the fracture site are an indication for operative management.
        - Open depressed fractures that are less than 1cm depressed and have no dural penetration, no significant intracranial hematomas, no frontal sinus involvement, no gross cosmetic deformity, no pneumocephalus, and/or no gross wound contamination may be non-operatively.
        - All open skull fractures should be considered for treatment with prophylactic IV antibiotics with CSF penetration.

#### References

1. Brain Trauma Foundation, Guidelines for the Management of Severe TBI, 4<sup>th</sup> ed. (braintrauma.org)
2. Brain Trauma Foundation, Povlishock JT, Bullock MR.<span style="mso-spacerun: yes;"> </span>Cerebral perfusion thresholds. J Neurotrauma 2007; 24: S59-S64
3. Brain Trauma Foundation, Povlishock JT, Bullock MR.<span style="mso-spacerun: yes;"> </span>Hyperventilation. J Neurotrauma.<span style="mso-spacerun: yes;"> </span>2007; 24:S87-S90

# Modified Brain Injury Guidelines (mBIG)

mBIG guidelines apply only to adult trauma patients (18 yrs and older). Pediatric trauma patients (less than 18 yrs of age) are excluded from these guidelines and neurosurgical consultation should be obtained for any intracranial hemorrhage.

#### **Modified Brain Injury Guidelines (mBIG)**  


<div drawio-diagram="21"><img src="https://paths.trauma.ai/uploads/images/drawio/2023-05/drawing-4-1683660587.png" alt=""/></div>

##### **Treatment Plans:**

##### **<u><span style="font-size: 9.0pt; line-height: 107%;">mBIG 1:</span></u>**

- <span style="font-size: 9.0pt; line-height: 107%;">Place in observation (2OBS) if isolated head injury, otherwise admit to appropriate level of care</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Neuro checks q2 hours (if in 2OBS), otherwise neuro checks q4 hours</span>
- <span style="font-size: 9.0pt; line-height: 107%;">If exam stable after 6 hours in 2OBS, discharge if GCS 15 </span>
- <span style="font-size: 9.0pt; line-height: 107%;">No Keppra, no BP goals, OK to start DVT prophylaxis if not being discharged after 6 hours</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Follow-up with neurocritical care outpatient\*\* </span>

**<u><span style="font-size: 9.0pt; line-height: 107%;">mBIG 2:</span></u>**

- <span style="font-size: 9.0pt; line-height: 107%;">Admission to SDCC if isolated head injury, otherwise admit to appropriate level of care</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Neuro checks q2 hours</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Repeat CT-head at 6 hours, OK to start DVT prophylaxis after 24 hours from stable head CT</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Neuro checks q4 hours after 24 hours observation</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Keppra 7 days, no BP goals</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Follow-up with neurocritical care outpatient\*\*</span>

**<u><span style="font-size: 9.0pt; line-height: 107%;">mBIG 3:</span></u>**

- <span style="font-size: 9.0pt; line-height: 107%;">Neurosurgery consultation</span>
- <span style="font-size: 9.0pt; line-height: 107%;">Follow-up with neurosurgery outpatient</span>

<div drawio-diagram="23"><img src="https://paths.trauma.ai/uploads/images/drawio/2023-05/drawing-4-1683661033.png" alt=""/></div>

# Pharmaceutical Management of Post-TBI Neuropsychiatric Symptoms

**<u>Definitions</u>**

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Depression: TBI-associated depression is characterized by prolonged, persistent sadness associated with other symptoms such as anhedonia, lack of motivation, decreased self-care, variable sleep and/or appetite pattern, feelings of hopelessness, and/or suicidal thoughts. These symptoms may last for a couple of weeks to months (major depressive episode) or persist in a milder form for two or more years (dysthymia).

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Mania/Agitation: Subtype of delirium unique to TBI which occurs during period of Post traumatic amnesia (PTA – period of time in which new memory formation is impaired), characterized by excess of behavior that includes some combination of aggression, disinhibition, akathisia, disinhibition, and emotional liability IN ABSENCE of other physical, medical or psychiatric causes.

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Anxiety: A wide range of anxiety disorders may occur after TBI including generalized anxiety disorder, agoraphobia, social phobia, panic disorder, and obsessive-compulsive disorder.

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>PTSD: Symptoms may include nightmares or unwanted memories of the trauma, avoidance of situations that bring back memories of the trauma, heightened reactions, anxiety, or depressed mood.

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Psychosis: There are predominantly 2 types of TBI-related psychosis: delusional disorders and schizophrenia-like psychosis.

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Sleep disturbance: Sleep disturbances are common after TBI and can occur in isolation or as a symptom of a psychiatric disorder. Insomnia is the most common sleep disturbance, seen in about 50% of patients with TBI, although other disturbances such as hypersomnia, sleep apnea, and sleepwalking may also be present.

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">7.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Executive function deficits: The constellation of cognitive impairments following TBI is variable and depends on the severity of the location of the injury on the brain. TBI can affect every cognitive domain, including attention, memory, visual-spatial processing, language, social cognition, and executive functioning.

**<u>Assessment and Diagnosis</u>**

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Mania/Agitation- Agitated Behavior Scale where 22-28 is mild agitation, 29-35 is moderate agitation, and 36-56 is severe agitation.<span style="mso-spacerun: yes;"> </span>

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Depression- PHQ 9 where 1-4 is minimal depression, 5-9 is mild depression, 10-14 is moderate depression, 15-19 is moderately severe depression and 20-27 is severe depression

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Anxiety: GAD-7 where 0-4 is minimal anxiety, 5-9 is mild anxiety, 10-14 is moderate anxiety, and 15-21 is severe anxiety

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>PTSD: ITSS where PTSD is evaluated in items 3, 4, 7, 8, 9 and Depression is evaluated in items 1, 2, 3, 5, 6. <span style="mso-spacerun: yes;"> </span>If the sum of questions 1, 2, 3, 5, and 6 is equal to or greater than 2, the screen is positive for PTSD risk.<span style="mso-spacerun: yes;"> </span>If the sum of questions 3, 4, 7, 8 and 9 is equal to or greater than 2, the screen is positive for depression risk.

<span style="mso-fareast-font-family: Calibri;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Memory deficits, executive function deficits, and inattention: consult Speech Therapy for cognitive evaluation

**<u>Pharmacologic Management</u>**

General Considerations for all patients:

Propranolol - Patients with TBI by CT and GCS &lt;12, hemodynamically stable at 24 hrs after admission (BP&gt;100, not requiring vasopressor or blood transfusion) should be started on propranolol 20 mg po q12hrs .<span style="mso-spacerun: yes;"> </span>If patient develops bradycardia (HR&lt;50 bpm) or hypotension (SBP &lt;100mmHg), then propranolol should be stopped.<span style="mso-spacerun: yes;"> </span>Increase the dose from 20 mg BID to 40 mg BID based upon SBP&gt;140s, and HRs&gt; 110-120s.<span style="mso-spacerun: yes;"> </span>(Of note, if BP remains high, consider adding another agent). Propranolol should be stopped upon discharge or after 7 days, whichever is sooner.

In patients on home beta-blockers (for hypertension, heart failure, afib rate control), switch to propranolol temporarily and stop the home beta blocker (avoid ordering 2 beta blockers on the same patient).<span style="mso-spacerun: yes;"> </span>Propranolol dose can be titrated up if needed for BP or HR) or a second antihypertensive ordered.

Clonidine – has unclear role for use in TBI patients for agitation or storming. Its use as adjunct therapy in withdrawal syndromes is longstanding. It is explored for use as a transition-off agent in patients on dexmedetomidine and as an adjunct in treating PSH.<span style="mso-spacerun: yes;"> </span>Thus, practical uses for clonidine include: treating agitation in conjunction with withdrawal syndromes, treating agitation/delirium in a patient weaning off dexmedetomidine or whom dexmedetomidine was effective, 3-4th line in PSH (after gabapentin, opiates, benzos have been tried/considered). Initial dosing should be 0.1 mg PO TID. If patient is already on dexmedetomidine, the dose can be started at 0.2-0.3 mg TID and the dexmedetomidine can be decreased. Side effects include: hypotension, rebound hypertension, withdrawal.

Antipsychotics and stimulants– Generally for short-term use, should be tapered when symptoms resolve.<span style="mso-spacerun: yes;"> </span>Use assessment tools prior to initiation of pharmacologic agents to ensure you are treating the correct symptom.

 ***All new antipsychotics and stimulants should be reviewed and weaned (if possible) at time of transfer from ICU to floor, and again, at time of discharge from hospital.***

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-psychiatric-problems" style="width: 539.5pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="719"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 56.6pt;"><td style="width: 129px; border: 1pt solid windowtext; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="129"><span style="color: rgb(0, 0, 0);">**<a name="_Hlk155860049" style="color: rgb(0, 0, 0);"></a>Psychiatric problems**</span>

</td><td style="width: 106.467px; border-width: 1pt 1pt 1pt medium; border-style: solid solid solid none; border-color: windowtext windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">**Assessment tool**</span>

</td><td style="width: 134.6px; border-width: 1pt 1pt 1pt medium; border-style: solid solid solid none; border-color: windowtext windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">**First line medications**</span>

</td><td style="width: 175.6px; border-width: 1pt 1pt 1pt medium; border-style: solid solid solid none; border-color: windowtext windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">**Standard dosage**</span>

</td><td style="width: 173.667px; border-width: 1pt 1pt 1pt medium; border-style: solid solid solid none; border-color: windowtext windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">**Common adverse effects**</span>

</td></tr><tr style="mso-yfti-irow: 1; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Depression</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">PHQ 9</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Sertraline</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start: 25 or 50 mg daily.</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">May double dose after 1 week, assess for effect in 4 weeks before further increasing.</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Nausea, diarrhea, sexual dysfunction</span>

</td></tr><tr style="mso-yfti-irow: 2; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Manic: acute</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">Agitated Behavior Scale</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Quetiapine</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start: 25-50 mg BID</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">Increase to effect to maximum of 400 mg/day</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Sedation, Parkinsonism, weight gain, QTc prolongation</span>

</td></tr><tr style="mso-yfti-irow: 3; height: 56.6pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Mania: maintenance</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">Agitated Behavior Scale</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Valproate</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start: 250 mg TID</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">May load with 15 mg/kg<span style="mso-spacerun: yes;"> </span>for rapid symptom control</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">May increase every 2-3 days, checking level to ensure not above range</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Hepatotoxicity, hyperammonemia, thrombocytopenia, drug interaction with carbapenems</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">Safe therapeutic range: 50-125 mcg/mL</span>

</td></tr><tr style="mso-yfti-irow: 4; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Anxiety</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">GAD-7</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Sertraline</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start: 25 mg daily</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">May double dose every 2 weeks until 100 mg daily reached. Assess in 4 weeks before further increasing.</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Nausea, diarrhea, sexual dysfunction</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">Low dosing to avoid worsening anxiety during initiation period</span>

</td></tr><tr style="mso-yfti-irow: 5; height: 56.6pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">PTSD</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">ITSS</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Sertraline or paroxetine</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;"><u>Sertraline</u></span>

<span style="mso-categorymark: _Hlk155860049;">Follow anxiety dosing</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;"><u>Paroxetine</u></span>

<span style="mso-categorymark: _Hlk155860049;">Start: 20 mg daily, may increase in 10 mg increments per week up to 60 mg daily.</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 56.6pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Nausea, diarrhea, sexual dysfunction </span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">Paroxetine has higher sedating effect.</span>

</td></tr><tr style="mso-yfti-irow: 6; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Psychosis</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;"> </span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Risperidone or quetiapine</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;"><u>Quetiapine</u></span>

<span style="mso-categorymark: _Hlk155860049;">Acute dose: 25 mg</span>

<span style="mso-categorymark: _Hlk155860049;">If scheduled dose indicated, same as above.</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;"><u>Risperidone </u></span>

<span style="mso-categorymark: _Hlk155860049;">Acute dose: 1-2 mg, up to 6 mg in 24 hours</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Parkinsonism, sedation</span>

</td></tr><tr style="mso-yfti-irow: 7; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Apathy</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;"> </span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Methylphenidate</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start: 5 mg BID</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Agitation, anxiety, insomnia, palpitations, tachycardia</span>

</td></tr><tr style="mso-yfti-irow: 8; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Sleep disturbance</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;"> </span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Melatonin</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">2<sup>nd</sup> line: Trazodone</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;"><u>Melatonin</u></span>

<span style="mso-categorymark: _Hlk155860049;">3-9 mg nightly</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;"><u>Trazadone</u></span>

<span style="mso-categorymark: _Hlk155860049;">50 mg nightly </span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Daytime drowsiness, sensory distortion, sleep walking</span>

</td></tr><tr style="mso-yfti-irow: 9; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Executive function deficits</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">Consult Speech Therapy for cognitive evaluation</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Amantadine</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start 100 mg BID</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

<span style="mso-categorymark: _Hlk155860049;">May increase in 50 mg increments weekly to max of 200 mg BID</span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Headache, nausea, diarrhea, insomnia, orthostasis, psychosis at high doses</span>

</td></tr><tr style="mso-yfti-irow: 10; mso-yfti-lastrow: yes; height: 53.45pt;"><td style="width: 129px; border-width: medium 1pt 1pt; border-style: none solid solid; border-color: currentcolor windowtext windowtext; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="129"><span style="mso-categorymark: _Hlk155860049;">Inattention</span>

</td><td style="width: 106.467px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="106"><span style="mso-categorymark: _Hlk155860049;">Consult Speech Therapy for cognitive evaluation</span>

</td><td style="width: 134.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="118"><span style="mso-categorymark: _Hlk155860049;">Methylphenidate</span>

</td><td style="width: 175.6px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="193"><span style="mso-categorymark: _Hlk155860049;">Start: 5 mg BID, start &gt;7-10 days post injury</span>

<span style="mso-categorymark: _Hlk155860049;"> </span>

</td><td style="width: 173.667px; border-width: medium 1pt 1pt medium; border-style: none solid solid none; border-color: currentcolor windowtext windowtext currentcolor; padding: 0in 5.4pt; height: 53.45pt;" valign="top" width="174"><span style="mso-categorymark: _Hlk155860049;">Agitation, anxiety, insomnia, palpitations, tachycardia</span>

</td></tr></tbody></table>

Appendix A: Agitated Behavior Scale where 22-28 is mild agitation, 29-35 is moderate agitation, and 36-56 is severe agitation.<span style="mso-spacerun: yes;"> </span>

<div id="bkmrk--0" style="mso-element: comment-list;"><div style="mso-element: comment;"><div class="msocomtxt" id="bkmrk--15" language="JavaScript" onmouseout="msoCommentHide('_com_8')" onmouseover="msoCommentShow('_anchor_8','_com_8')"></div></div></div>[![image.png](https://paths.trauma.ai/uploads/images/gallery/2024-01/scaled-1680-/image.png)](https://paths.trauma.ai/uploads/images/gallery/2024-01/image.png)

Appendix B: PHQ 9 where 1-4 is minimal depression, 5-9 is mild depression, 10-14 is moderate depression, 15-19 is moderately severe depression and 20-27 is severe depression

[![image.png](https://paths.trauma.ai/uploads/images/gallery/2024-01/scaled-1680-/mCYimage.png)](https://paths.trauma.ai/uploads/images/gallery/2024-01/mCYimage.png)

Appendix C: GAD-7 where 0-4 is minimal anxiety, 5-9 is mild anxiety, 10-14 is moderate anxiety, and 15-21 is severe anxiety

[![image.png](https://paths.trauma.ai/uploads/images/gallery/2024-01/scaled-1680-/Lngimage.png)](https://paths.trauma.ai/uploads/images/gallery/2024-01/Lngimage.png)

Appendix D: ITSS where PTSD is evaluated in items 3, 4, 7, 8, 9 and Depression is evaluated in items 1, 2, 3, 5, 6.<span style="mso-spacerun: yes;"> </span>If the sum of questions 1, 2, 3, 5, and 6 is equal to or greater than 2, the screen is positive for PTSD risk.<span style="mso-spacerun: yes;"> </span>If the sum of questions 3, 4, 7, 8 and 9 is equal to or greater than 2, the screen is positive for depression risk.

[![image.png](https://paths.trauma.ai/uploads/images/gallery/2024-01/scaled-1680-/Lnsimage.png)](https://paths.trauma.ai/uploads/images/gallery/2024-01/Lnsimage.png)

Authors:

Charity Evans, Abby Josef Trauma and Acute Care Surgery

Becca Sedlak, Pharmacy

Last Updated: January 2024

<div id="bkmrk--14" style="mso-element: comment-list;"><div style="mso-element: comment;"><div class="msocomtxt" id="bkmrk--16" language="JavaScript" onmouseout="msoCommentHide('_com_28')" onmouseover="msoCommentShow('_anchor_28','_com_28')">  
</div></div></div>

# Initial Assessment and Management of Spine Injury

#### Purpose

To provide an evidence-based, practical guide to the evaluation and management of an adult patient with a spinal injury, including both spinal column fracture (SCF) and spinal cord injury (SCI).

#### Background/Definitions

Although fractures of the spine represent a small proportion of all fractures from traumatic injury overall (incidence ranging from 4-23 percent), their impact on the individual and the healthcare system is significant due to the potential for long-term disability, associated health care consequences and costs. Additionally, the incidence of traumatic spinal injuries is expected to increase globally as the population ages. Optimal outcomes are closely related to rapid identification of injuries, early surgical intervention when necessary and early mobilization.

#### Guideline Inclusion Criteria 

Adult Trauma patients (15 yrs and older) with spinal column fracture (SCF) and/or spinal cord injury (SCI).

#### Guideline Exclusion Criteria 

Pediatric trauma patients (Less than 15 yrs of age)

#### Diagnostic Evaluation 

- All trauma patients should be initially evaluated per ATLS guidelines, independent of whether an SCF or SCI is suspected or confirmed.
- Cervical and thoracolumbar spinal motion restriction (SMR) should be maintained throughout this evaluation. 
    - - DO NOT use force to move the patient’s neck or thoracolumbar spine into a position that elicits pain.
        - Perform examinations of the spine by log rolling the patient when necessary.
- Examination of the cervical, thoracic, lumbar and sacral spine should include the following: 
    - - Gross inspection for abrasions, contusions, hematomas, open wounds, and obvious spinal deformities.
        - Systematically palpate the entire spine to evaluate for pain, tenderness, step offs, gaps or any other deformities.
        - When a SCI is suspected, perform a digital rectal exam (DRE) before rolling the patient back to the supine position.
    - <span style="mso-bidi-font-weight: bold;">NOTE: physical examination of the spine has low sensitivity for injury. Level of pain and/or tenderness often do not correlate with level of injury on imaging. A normal exam has low sensitivity in ruling out spinal injuries. </span>
- Imaging of the spine **should be obtained** in any patient that has new/acute pain on examination or new neurologic deficit following a traumatic event.
- Imaging of the spine **should be considered** in trauma patients who present with severe injuries at high risk for associated spinal trauma including traumatic brain injury (TBI), complex maxillofacial trauma, pelvic fractures, thoracic trauma, calcaneal fractures resulting from fall from height, and presence of seat-belt sign. Imaging the spine should also be considered with certain mechanisms of injury including high speed motor vehicle collisions (especially when associated with ejection or roll over), motorcycle/bicycle/ATV or UTV collisions, crush injuries, falls from height, or injuries leading to an axial load on the head (e.g. diving and peds vs auto).
- Age by itself, is considered a high-risk factor for spinal trauma and spinal imaging should be taken into consideration even after low-energy mechanisms such as ground level falls.
- Computed tomography (CT) of the cervical, thoracic, and lumbar spine is the preferred initial imaging modality.

#### Practice Recommendations for Management

- Once spine fracture is identified on imaging or if acute neurologic deficit present/SCI suspected, consult the appropriate spine surgery service (Orthopedic Spine or Neurosurgery Spine) based on call schedule. 
    - - **EXCEPTION**: 3 or fewer isolated and unilateral transverse or spinous process fractures located in the thoracolumbar spine DO NOT require a spine consult
- <span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Spine service will evaluate patient and address the following issues (if able) in consultation note: 
    - - Fractures present 
            - - Stable vs unstable
        - Spinal cord injury present 
            - - Level/ASIA grade
                - Blood pressure goals and length of goals
                - Other specific concerns (i.e. presence of epidural hematoma, etc)
        - Frequency of neurological exams
        - Additional imaging
        - Injury operative or non-operative
        - Need for brace/what type of brace
        - Activity restrictions (i.e. maintain full spine precautions, OK for HOB 30 deg, OK for activity in brace, etc)
        - Recommendations regarding initiation of DVT prophylaxis
        - Attending surgeon staffing consult
- Operative vs non-operative management of SCF will be at the discretion of the consulting spine service and based on patient exam and fracture pattern/stability.

- On admission: 
    - - Patient should be initiated on a multi-modality pain regimen to include the following (if not contraindicated): 
            - - Acetaminophen 1000 mg q 8 hrs
                - Calcitonin 200 IU per day intranasally
                - Lidocaine 5% patch to affected area for 12 hrs
                - Cyclobenzaprine 10 mg q 8 hrs (avoid in elderly)
                - Oxycodone (avoid in elderly)
                - Ibuprofen 800 mg q 8 hrs
                - Gabapentin 300 mg q 8 hrs
        - Activity orders
        - Appropriate bracing should be ordered.
        - Additional consults: physical therapy (PT), occupational therapy (OT) 
            - - Consider speech consult in patients with cervical fractures and complaints of dysphonia or dysphagia
                - PM&amp;R consult for patients with SCI

- Non-operative spine fractures: 
    - - Within 24 hrs of admission: 
            - - Appropriate brace delivered to bedside
                - Ambulate with nursing staff and/or physical therapy (if not on full spine precautions or limited by concomitant injuries)
                - Upright X-rays or additional imaging ordered and obtained. 
                    - - Once upright X-rays obtained, contact the appropriate spine service for interpretation and additional recommendations.
                        - Spine service will provide interpretation and additional recommendations within 6hrs of being notified x-rays are complete.<span style="mso-spacerun: yes;"> </span>
                        - If upright x-rays are unable to be obtained within 48 hrs of admission, notify spine service and discuss alternatives.
        - 24-48 hrs of admission: 
            - - PT/OT evaluations completed with disposition recommendations.
                - Social work and case management engaged in disposition and discharge planning.

- Operative spine fractures: 
    - - Surgical decompression or stabilization of SCF will ideally be performed within 72 hrs of admission in attempt to optimize outcomes and minimize morbidity related to delayed operative intervention. 
            - - If patient unable to undergo recommended operative intervention within 72 hours, document why (i.e. patient factors, OR availability, surgeon availability).
        - Within 24 hrs post-operatively: 
            - - Appropriate brace delivered to bedside (if required)
                - Ambulate with nursing staff and/or physical therapy
                - Upright X-rays or additional imaging ordered and obtained. 
                    - - Once upright X-rays obtained, contact the appropriate spine service for interpretation and additional recommendations.
                        - Spine service will provide interpretation and additional recommendations within 6hrs of being notified x-rays are complete.<span style="mso-spacerun: yes;"> </span>
        - 24-48 hrs post-operatively: 
            - - PT/OT evaluations completed with disposition recommendations.
                - Social work and case management engaged in disposition and discharge planning.

#### Follow-up Care

<span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patients with SCF and/or SCI will follow-up at the discretion of the consulting spine service in the post-hospital setting.

#### Outcome Measures and Guideline Adherence

- All trauma patients with SCF and/or SCI experiencing a complication will be reviewed by our Trauma PI team for compliance with spinal injury guidelines.
- 6 months following implementation of guidelines, timing to OR for operative spinal injuries and length of stay will be reviewed for compliance and opportunities for improvement.

#### Related Policies

Cervical spine clearance

#### Key Contributors

- Emily Cantrell, MD <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">| Division of Acute Care Surgery, Faculty<span style="mso-spacerun: yes;"> </span></span>
- Charity Evans, MD <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">| Division of Acute Care Surgery, Faculty </span>
- Daniel Surdell, MD <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">| Department of Neurosurgery, Faculty </span>
- Miki Katzir, MD <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">| Department of Neurosurgery, Faculty </span>
- Jamie Wilson, MD <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">| Department of Neurosurgery, Faculty </span>
- Scott Vincent, MD <span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;">| Department of Orthopedic Surgery, Faculty </span>

#### Last Updated

March, 2024

#### References

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>American College of Surgeons. Trauma Quality Improvement Program Spine Injury Best Practice Guidelines. [spine\_injury\_guidelines.pdf (facs.org)](https://www.facs.org/media/k45gikqv/spine_injury_guidelines.pdf)

# Transverse and Spinous Process Fractures

**<span style="font-size: 12.0pt; color: #212121;">Background:</span>**

<span style="font-size: 12.0pt; color: #212121;">The majority of transverse process (TP) and spinous process (SP) fractures are structurally and neurologically stable injuries, which do not require spine service intervention. However there are some features which can be more worrisome for associated spinal cord and/or ligamentous involvement. Transverse process fractures are defined as those involving the transverse process only, **without** extension into the pedicle, lamina, or facet complex. <span class="ILfuVd" lang="en"><span class="hgKElc">The spinous process **serves to attach muscles and ligaments,** which are therefore at risk for injury in the presence of an SP fracture. </span></span>We sought to create inclusion criteria to ensure that consistent spine consultation is obtained for the most high risk of these generally low-risk, stable fractures.  
</span>

**<span style="font-size: 12.0pt; color: #212121;">Guidelines for medical decision-making:</span>**

<span style="font-size: 12.0pt; color: #212121;">Trauma patients will receive imaging per usual protocol at the discretion of the treating team. TP and/or SP fractures may be identified on CT scan. If present, the following are indications for a spine consult:</span>

<span style="font-size: 12.0pt; font-family: Symbol; color: #212121;">·</span><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: #212121;"> <span class="apple-converted-space"> </span></span><span style="font-size: 12.0pt; color: #212121;">4 or more contiguous TP fractures / SP fractures<span class="apple-converted-space"> </span></span>

<span style="font-size: 12.0pt; font-family: Symbol; color: #212121;">·</span><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: #212121;"> <span class="apple-converted-space"> </span></span><span style="font-size: 12.0pt; color: #212121;">Bilateral TP fractures / SP fractures (regardless of the # of fractures)</span>

<span style="font-size: 12.0pt; font-family: Symbol; color: #212121;">·</span><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; color: #212121;"> <span class="apple-converted-space"> </span></span><span style="font-size: 12.0pt; color: #212121;">All C-spine TP fractures / SP fractures</span>

<span style="font-size: 12.0pt; color: #212121;"> </span>

<span style="font-size: 12.0pt; color: #212121;">Additionally, Spine consultation is required for ANY fracture (including TP and SP) when a concern for ligamentous injury exists.</span>

**<span style="font-size: 12.0pt; color: #212121;">Key contributors:</span>**

<span style="font-size: 12.0pt; color: #212121;">Abby Josef, Trauma</span>

<span style="font-size: 12.0pt; color: #212121;">Reviewed by: Jamie Wilson, Neurosurgery and Scott Vincent, Ortho Spine</span>

**<span style="font-size: 12.0pt; color: #212121;">Version Date:</span>**

<span style="font-size: 12.0pt; color: #212121;">January 2024</span>

**<span style="font-size: 12.0pt; color: #212121;">References:</span>**

A. Homnick et al. Isolated thoracolumbar transverse process fractures: call physical therapy, not spine. J Trauma. (2007)

L.H. Bradley et al. Isolated transverse process fractures: spine service management not needed. J Trauma (2008)

J. H. Boulter et al. Implications of isolated Transverse Process fractures: Is spine service consultation necessary? World Neurosurgery (2016)

# Care of Patients with Spinal Cord Injuries Practice Guideline

**<u><span style="font-family: 'Arial',sans-serif;">Purpose:</span></u>**<span style="font-family: 'Arial',sans-serif;"><span style="mso-spacerun: yes;"> </span>To optimize the care of the spinal cord injured patient and prevent secondary complications.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Admission:</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;"><span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">All traumatic SCI patients will be admitted to ICU level of care with either Neurosurgery or Ortho Spine consult.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Spine Stabilization:</span></u>**

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Patients with SCI should have unstable spinal injuries stabilized as early as possible, goal is within 24-48 hours post injury.</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Optimize other injuries in multisystem injured patients with SCI to facilitate early spinal surgical stabilization.</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Patients with SCI should be on bedrest until cleared by Neurosurgery/Ortho Spine.<span style="mso-spacerun: yes;"> </span>Once spinal injury is stabilized, activity should be liberated.</span>

**<span style="font-family: 'Arial',sans-serif;"> </span>**

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-%C2%A0-phase-1%3A-icu-phase" style="border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<u><span style="font-family: 'Arial',sans-serif;"><span style="text-decoration: none;"> </span></span></u>**

</td><td style="width: 274.5pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366">**<u><span style="font-family: 'Arial',sans-serif;">Phase 1: ICU</span></u>**

</td><td style="width: 156.0pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208">**<u><span style="font-family: 'Arial',sans-serif;">Phase 2: Step-down or Floor</span></u>**

</td></tr><tr style="mso-yfti-irow: 1;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Neurological</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Neuro assessments per unit protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Additionally, a neuro assessment should be performed and documented by nursing after any transfer (to new bed, new room, any procedure, etc).<span style="mso-spacerun: yes;"> </span></span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Provider should be immediately notified of any changes in neuro exam.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Arial',sans-serif;">Follow phase 1.</span>

</td></tr><tr style="mso-yfti-irow: 2;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Pain/Spasticity</span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Assess pain per unit protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Initiate multimodal pain regimen.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Neuropathic Pain:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Pregabalin 75mg po q12h (can increase to 150 mg q12h at one week if needed) (reduce dosage if creatinine clearance is &lt; 60mL/min)</span>

<span style="font-family: 'Arial',sans-serif; mso-bidi-font-weight: bold;"><span style="mso-spacerun: yes;"> </span>OR</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Gabapentin 300 mg po q8h; &gt; 65 years, 100 mg q8h (max 3600mg/day)<span style="mso-spacerun: yes;"> </span></span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult pharmacy for titration. Should be weaned off over 1-2 weeks before discontinuing. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Initiate medication soon after injury.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Spasticity:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Baclofen 10mg PO TID (max 120mg/day).</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">If minimal response to Baclofen, start Dantrolene 25mg PO Q 24 hrs; may titrate every 7 days to max of 400mg/day. **Monitor LFTs weekly while actively titrating Dantrolene.**</span>

**<u><span style="font-family: 'Arial',sans-serif;">Muscle Spasms:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Carisoprodol 350 mg po q6h PRN</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">OR</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Cyclobenzaprine 10 mg po q8h PRN</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208">**<u><span style="font-family: 'Arial',sans-serif;"><span style="text-decoration: none;"> </span></span></u>**

</td></tr><tr style="mso-yfti-irow: 3;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Respiratory</span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif; color: red;"> </span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366">**<u><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">All Patients:</span></u>**

<span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-bidi-font-weight: bold;">Monitoring: Continuous pulse oximetry &amp; EtCO2 for 7-10 days in patients with high cord injury and/or risk of respiratory compromise</span><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-bidi-font-weight: bold;">.</span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-bidi-font-weight: bold;"> <span style="mso-spacerun: yes;"> </span>Assess neurological level of injury daily.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For high cervical spine injuries (C6 and above): <span style="mso-spacerun: yes;"> </span>Consider daily ABG for 1-2 weeks post injury, with indications for escalation of respiratory support (including intubation) if PaO2 &lt; 50 or PaCO2 &gt; 50 on room air.<span style="mso-spacerun: yes;"> </span></span>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1; mso-bidi-font-weight: bold;">Consider monitoring with serial determination of the vital capacity, FEV1, the peak expiratory flow rate, the negative inspiratory force (NIF). If declining trend, order CXR and ABG with considerations as above.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Pts with weak cough, initiate manually assisted coughing (quad cough) Q 4 hrs.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Implement strict oral cares routine: every 2-4hrs and prn for intubated or unconscious patients; all other patients at minimum once per shift.</span>

**<u><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Non-Intubated:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Incentive spirometry (IS) Q 1hr while awake.<span style="mso-spacerun: yes;"> </span>Nursing to document volume achieved.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">If achieved IS volume &lt; 50% predicted, consult Respiratory Therapy (RT) for lung volume expansion. RT Consult in all C spine and upper thoracic injuries- Pulmonary function test + possible addition of oscillatory positive expiratory pressure (OPEP), chest percussion therapy (CPT). Assisted Cough, IPV</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;"><span style="mso-spacerun: yes;"> </span></span>

**<u><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Intubated:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">In adults: Implement adult ventilator management EPIC order set which includes VAP bundle and ventilator weaning protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Assess need for respiratory suctioning frequently to avoid mucous plugging.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Consider higher tidal volumes (TV) of 10-15 cc/kg to resolve or prevent atelectasis, if no contraindications.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider early tracheostomy who are likely to remain ventilator dependent or to wean slowly from mechanical ventilation. (&lt;7 days)</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Consult Speech Therapy (ST) to start Passy Muir Valve (PMV) trials</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">If not unable to tolerate or inappropriate for PMV, consult ST for alternate communication methods. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Consider downsizing trach as early as possible.</span>

**<u><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Secretions:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Consider bronchoscopy.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">3% saline nebulized Q 8 hrs.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Add Guaifenesin</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Consult RT for possible addition of oscillatory positive expiratory pressure (OPEP), chest percussion therapy (CPT), cough assist, IPV</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Follow phase 1 non-intubated patient.</span>

**<u><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Trach:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Consider larger TV (see phase 1 for parameters).</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">If remains on ventilator,**<u> </u>**continue weaning per protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">If not completed in phase 1, consult ST for PMV and/or alternate communication methods.</span>

**<u><span style="font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Secretions:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Same as phase 1.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; color: black; mso-themecolor: text1;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-themecolor: text1;">Discontinue therapies when secretions become thin.</span>

</td></tr><tr style="mso-yfti-irow: 4; height: 83.65pt;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 83.65pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Cardiac</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 83.65pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Vital signs per unit protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Prevent and treat hypotension.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Hypotension:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">MAP Goal ≥ 80 x minimum 3-7 days (per Spine consult recommendations) from injury for ASIA A-D injuries.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Utilize Norepinephrine as first line agent.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Place arterial line for accurate hemodynamic monitoring.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Obtain central access if utilizing vasopressors.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">If persistent vasopressor requirement &gt; 3 days: Consider Midodrine 5 mg po q8h, titrate up to 40 mg/day.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Apply TED hose and /or ACE wraps to bilateral extremities when getting out of bed to chair, remove once back in bed.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Bradycardia:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Assess for presence of mucus plugs (most common cause of acute bradycardia).</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Order Atropine 0.5mg IV q1h prn for HR &lt; 40 and have available at bedside.</span>

*<span style="font-family: 'Arial',sans-serif;">If persistent symptoms of bradycardia:</span>*

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Start Robinul 0.1-0.2 mg IV or 1-2 mg po q8h to q12h. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider external or temporary pacemaker to maintain HR &gt; 60.<span style="mso-spacerun: yes;"> </span></span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">If pacing required, consult cardiology.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 83.65pt;" valign="top" width="208">**<u><span style="font-family: 'Arial',sans-serif;">Hypotension:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Must be weaned off vasopressors prior to transfer out of ICU.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Continue or initiate Midodrine doses from phase 1 if needed.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Monitor for need or wean dose as tolerates.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Continue TED hose and/or ACE wraps from phase 1 when out of bed.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Bradycardia:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1.</span>

</td></tr><tr style="mso-yfti-irow: 5;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Gastrointestinal</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Gastrointestinal assessment per unit protocol. Monitor for nausea, vomiting, signs and symptoms of an ileus. Monitor for incontinence.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Initiate bowel regimen on admission.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Nursing to notify provider if patient goes more than a day without BM</span>

**<u><span style="font-family: 'Arial',sans-serif;">Stress Ulcer Prophylaxis:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Initiate and continue while patient remains ventilated.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Discontinue once patient off ventilator and tolerating goal tube feeds or regular diet x 48 hrs.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Bowel Care (Prevent and Treat Constipation):</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Initial upper motor neuron (UMN) regimen: Colace 100 mg po tid, Senna 17.6 mg 8-12 hours prior to digital simulation (typically given at lunch for nighttime digital stimulation) and Dulcolax 10 mg per rectum given along with digital stimulation.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Lower motor neuron (LMN) and mixed UMN/LMN injury regimen: Metamucil and manual stool evacuation. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">No large volume enemas scheduled or routine.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Once enteral feedings have begun, bowel care should be done consistently at the same time each day, regardless of involuntary stooling between scheduled bowel care.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Schedule Bowel Routine</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">: Dulcolax suppository at the same time daily with digital/manual stimulation.<span style="mso-spacerun: yes;"> </span>Discontinue only if excessive diarrhea.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Digital/Manual stimulation</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">: Position patient left side down. Always use lubricant for comfort and to prevent autonomic dysreflexia.<span style="mso-spacerun: yes;"> </span>Should be done with scheduled Dulcolax suppository.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">No BM by 72 hrs of admission</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">: Check for impaction by positioning left side down.<span style="mso-spacerun: yes;"> </span>No impaction then increase Dulcolax to Q 12 hrs and start Lactulose 20grams PO Q 12 hrs until first BM.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Diarrhea (liquid &gt;500cc every Q 8 hrs or &gt; 3 stools/day for 2 days):</span></u>**<span style="font-family: 'Arial',sans-serif;"><span style="mso-spacerun: yes;"> </span></span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Hold bowel regimen.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Start Metamucil 1 packet PO Q 12 hrs</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Start Nutrisource Fiber 1 packet TID PO prn.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider checking stool for C.Difficile Toxin.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Cervical level SCI requires 4 weeks of GI ppx</span>

</td></tr><tr style="mso-yfti-irow: 6;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Nutrition</span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult Speech Therapy for swallow evaluation prior to initiating any oral intake in any SCI patient with cervical spinal cord injury, prolonged intubation, tracheostomy, halo fixation, or after any cervical spine surgery.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Obtain feeding access and initiate enteral support within 48 hrs of injury if no evidence of ongoing shock or hypoperfusion and off IV vasopressors.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Nutrition consult for assessment of calorie and protein needs.<span style="mso-spacerun: yes;"> </span>Also to provide nutrition support recommendations.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Once full estimated needs are being consistently provided consider ordering indirect calorimetry and/or 24 hour urine urea nitrogen to determine adequacy of nutrition.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Order calorie count when transitioning patient off enteral nutrition to oral intake to assist with titration.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Obtain prealbumin, CBC, CMP, folate and vitamin B12 every Sunday.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Maintain normoglycemia.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1 - continue current diet orders.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Nutrition to continue to monitor/intervene as per consult.</span>

<span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Transition to oral diet, if not on one, once patient passes ST swallow evaluation.</span>

</td></tr><tr style="mso-yfti-irow: 7;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Genitourinary</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Genitourinary assessment per unit protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Place indwelling catheter unless contraindicated, catheter cares per policy.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Remove indwelling catheter once patient is hemodynamically stable and no longer needs strict I&amp;Os – then assess for volitional bladder control.</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>

<u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For patients without volitional bladder control:</span></u>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Once Foley is removed: STRICT q4h straight cath &amp; 2L fluid restriction.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">If volumes are consistently less than 400 mL, can stop fluid restriction and go to q6h straight cath schedule. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Nursing or OT to teach self-cath technique.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Once patient is on the floor, closely follow ins/outs to ensure cath schedule is followed.</span>**

**<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

<u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For patients with some volitional bladder control:</span></u>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Check PVR after emptying bladder to assess need for above regimen. </span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>

<u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For all patients:</span></u>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Outpatient urodynamic evaluation with Urology to be scheduled 3 months following injury.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1. Work towards schedule for time straight caths.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Encourage moderate fluid intake spaced out throughout day to facilitate timed straight caths.</span>

<span style="font-family: 'Arial',sans-serif;"> </span>

</td></tr><tr style="mso-yfti-irow: 8;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Integumentary</span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Skin checks Q shift, pay close attention to bony prominences and under medical devices.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Give extra caution when assessing darker skin complexions as early signs of pressure injuries can go unnoticed. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">If wound or skin concern identified, notify primary team and consult wound care per protocol.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Reposition pt at least every Q 2 hrs while maintaining spinal precautions (this includes all SCI pts –pre &amp; post spine fixation, halo traction).</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Position wedges above &amp; below bony prominences to offload pressure.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Order and utilize TAPS turning system.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Patient with c-spine injury must be turned WITH wedges, not pillows to at 30+ degrees. Side lying preferred. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Sand beds for c-spine patients. Consider for high T-spine injury or patients with BUE weight bearing restrictions and consult with PT/OT. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Place on low air loss mattress.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Avoid friction, shearing, moisture and heat. Keep areas under patient clean and dry.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Implement pressure injury prevention skin bundle.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider placing Mepilex sacral dressing to coccyx/sacrum.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Order PRAFO and Prevalon boots.<span style="mso-spacerun: yes;"> </span>Alternating between the two Q 2 hrs.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Incision and drain wound care per orders.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Maintain normothermia.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider specialty bed for floor</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Order ROHO or GeoMatt cushion for wheelchair, utilize any time pt out of bed in chair.</span>

</td></tr><tr style="mso-yfti-irow: 9;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Mobility &amp; Rehab</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult physical therapy (PT) and occupational therapy (OT) for evaluate and treat. (should be seen within the first week, even if sedated/intubated)</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult PM&amp;R.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For cervical spine injuries, continue c-collar at all times.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Utilize brace, if ordered, when HOB &gt; 30° and out of bed (confirm with neurosurgery).</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Splinting should be considered for all patients at risk of contracture. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Let fingers flex passively and DO NOT overextend. This can cause loss stretch-induced paresis. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Sip and puff call light if pancake call light isn’t sufficient. Can consult OT for assistance with hydration system. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult SLP for communication needs (eye gaze system, etc.) </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Early and aggressive mobilization.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Head of Bed:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-bidi-font-weight: bold;">A gradual increase in HOB elevation, beginning at 15–30 degrees and advancing to 45 degrees or higher as tolerated, to promote upright tolerance and reduce the risk of orthostatic hypotension. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Unstable spinal injury requiring surgical fixation:</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> Do not elevate HOB.<span style="mso-spacerun: yes;"> </span>Keep patient in reverse Trendelenburg unless contraindicated.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Stable fractures or post spinal fixation: </span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">HOB should remain elevated to at least 30° unless contraindicated. </span>

**<u><span style="font-family: 'Arial',sans-serif;">Activity:</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Unstable spinal injury requiring surgical fixation, bedrest until fixation occurs.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Once spinal stabilization has occurred, discontinue bedrest order and place activity order.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Passive ROM should be performed daily for all major joints to prevent contractures. Active ROM when able. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Assess patient with the Bedside Mobility Assessment Tool before initiation of out of bed mobility. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Goal: Out of bed to chair or wheelchair Q 12 hrs once medical and spinal stability has been achieved.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For best practice, while in chair recline pt every 30 mins for 2 minutes or every 15 mins for 1 minute to achieve pressure relief then return to full upright position.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider utilizing ROHO or GeoMatt cushion when in chair or wheelchair. </span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1, continue to increase activity as tolerates.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">PT/OT to assess need for orthotics of UE/LE.</span>

</td></tr><tr style="mso-yfti-irow: 10;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">VTE Prophylaxis</span>**

**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Pneumatic compression +/- Graduated compression stockings- ASAP when no LE injury C/I. Order SCDs, to be worn while in bed or sitting. (Including children of all ages)</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">No routine DVT screening.<span style="mso-spacerun: yes;"> </span></span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consider IVC filter if delay in starting chemical prophylaxis; otherwise no routine IVC filter placement.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Chemical VTE prophylaxis</span></u>**

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>**<u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">First line acute phase – Lovenox 30 mg BID. Recommendation against Heparin unless LMWH not available or contraindicated</span></u>**

<u><span style="font-family: 'Arial',sans-serif; mso-bidi-font-weight: bold;">Timing of initiation</span></u>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Stable spinal injury requiring no surgical fixation:</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> Initiate Lovenox 30mg BID 24 hr. after admission.<u> </u></span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Unstable spinal injury requiring surgical fixation: </span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Start DVT PPX <span style="mso-spacerun: yes;"> </span>24 hrs. post injury, if no other C/I and there is delay in OR for spine fixation. Hold morning dose on the day of surgery. </span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Unstable spinal injury post spinal fixation:</span></u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> &lt;48 hrs. (as early as 24 hrs. post is safe) after surgery initiate Lovenox 40mg Q daily for 5 or 7 days then can transition to Lovenox 30mg BID dosing. (Check with Surgeon)</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For patients with renal dysfunction, utilize Heparin 8000u SQ Q 8hrs.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Continue chemical prophylaxis for at least 8 weeks post injury in patients with limited mobility. Consider longer duration in motor complete injuries, lower-extremity fractures, older age, previous VTE, cancer, and obesity</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><u><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-bidi-font-weight: bold;">Rehab phase – LMWH preferred, other options warfarin (INR 2-3) or DOAC. </span></u>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Chemical VTE prophylaxis should be held prior to drain removal post-surgical fixation.<span style="mso-spacerun: yes;"> </span>Neurosurgery or Ortho spine to place this hold order.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Arial',sans-serif;">Continue SCDs and chemical DVT prophylaxis.</span>

</td></tr><tr style="mso-yfti-irow: 11;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Psychosocial</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult psychology.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Assess for depression.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Foster effective coping strategies.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Utilize assistive devices including specialty call lights and communication boards.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Identify, educate, and support family/caregivers.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">For pediatric patients or patients with children or younger siblings consult child life.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Follow phase 1.</span>

</td></tr><tr style="mso-yfti-irow: 12;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Discharge Planning </span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Communicate early with care transitions to determine disposition options.</span>

<span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Consult social work to facilitate placement.<span style="mso-spacerun: yes;"> </span></span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Arial',sans-serif;">Continue discharge planning.</span>

</td></tr><tr style="mso-yfti-irow: 13; mso-yfti-lastrow: yes;"><td style="width: 115.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="154">**<span style="font-size: 11.0pt; mso-bidi-font-size: 10.0pt; font-family: 'Arial',sans-serif;">Education</span>**

</td><td style="width: 274.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="366"><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Arial',sans-serif;">Begin teaching family and/or family/caregiver cares early on in stay once patient medically stable.</span>

**<u><span style="font-family: 'Arial',sans-serif;">Respiratory:</span></u>**<span style="font-family: 'Arial',sans-serif;"> How to manually assist coughing. Trach – suctioning and trach cares. </span>

<span style="font-family: 'Arial',sans-serif;"> </span>

**<u><span style="font-family: 'Arial',sans-serif;">Cardiac:</span></u>**<span style="font-family: 'Arial',sans-serif;"> How to apply TED hose or ACE wraps prior to getting patient out of bed.</span>

<span style="font-family: 'Arial',sans-serif;"> </span>

**<u><span style="font-family: 'Arial',sans-serif;">GI:</span></u>**<span style="font-family: 'Arial',sans-serif;"> Importance of bowel care schedule and how to manually stimulate.</span>

<span style="font-family: 'Arial',sans-serif;"> </span>

**<u><span style="font-family: 'Arial',sans-serif;">GU: </span></u>**<span style="font-family: 'Arial',sans-serif;">How to preform clean straight caths and catheter cares.</span>

<span style="font-family: 'Arial',sans-serif;"> </span>

**<u><span style="font-family: 'Arial',sans-serif;">Integumentary:</span></u>**<span style="font-family: 'Arial',sans-serif;"> Importance of maintaining skin integrity and frequent assessments of skin.</span>

<span style="font-family: 'Arial',sans-serif;"> </span>

**<u><span style="font-family: 'Arial',sans-serif;">Autonomic Dysreflexia (typically develops a few months post-SCI):</span></u>**<span style="font-family: 'Arial',sans-serif;"> Signs and symptoms, causes, prevention and treatment.</span>

</td><td style="width: 156.0pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="208"><span style="font-size: 10.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Continue to follow phase 1. Reinforce education and practice.</span>

</td></tr></tbody></table>

**Author and last update**

Keely Buesing, MD, Trauma &amp; Acute Care Surgery

Dan Pierce, MD, Physical Medicine &amp; Rehabilitation

January 2026

**<u><span style="font-family: 'Arial',sans-serif;">References:</span></u>**

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-color-alt: windowtext; background: white;">Beom, J., &amp; Seo, H. (2018). The need for early tracheostomy in patients with traumatic cervical cord injury. *Clinics in Orthopedic Surgery, 10*(2), 191-196. </span><span class="doi"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black;">doi: </span></span>[<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">10.4055/cios.2018.10.2.191</span>](https://dx.doi.org/10.4055%2Fcios.2018.10.2.191)

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Cabahug, P., Pickard, C., Edmiston, T., &amp; Lieberman, J. A. (2020). A Primary Care Provider's Guide to Spasticity Management in Spinal Cord Injury. *Topics in spinal cord injury rehabilitation*, *26*(3), 157–165. </span>[<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">https://doi.org/10.46292/sci2603-157</span>](https://doi.org/10.46292/sci2603-157)<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;"> </span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-color-alt: windowtext; background: white;">Consortium for Spinal Cord Medicine. (2008). Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals. *Journal of Spinal Cord Medicine, 31*(4), 403-479.<span style="mso-spacerun: yes;"> </span>doi: </span>[<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">10.1043/1079-0268-31.4.408</span>](https://dx.doi.org/10.1043%2F1079-0268-31.4.408)

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Dhall, S, Hadley, M., Aarabi, B., Gelb, D., Hurlbert, J., Rozzelle, C., Ryken, T., Theodore, N. &amp; Walters, B. (2013). Deep venous thrombosis and thromboembolism in patients with cervical spinal cord injuries. *Neurosurgery, 72,* 244-254. <span style="color: black; mso-color-alt: windowtext; background: white;">doi: 10.1227/NEU.0b013e31827728c0</span></span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Fehlings, M., Tetreault, L., Wilson, J., Aarabi, B., Anderson, P., Arnold, P., Brodke, D., Burns, A., Chiba, K., Dettori, J., Furlan, J., Hawryluk, G., Holly, L., Howley, S., Jeji, T., Kalsi-Ryan, S., Kotter, M., Kurpad, S., Marino, R., …Harrop, J. (2017). A clinical practice guideline for the management of patients with acute spinal cord injury and central cord syndrome: Recommendations on the time (≤ 24 hours versus &gt; 24 hours) of decompressive surgery.<span style="mso-spacerun: yes;"> </span>*Global Spine Journal, 7,* 195S-202S. <span style="color: black; mso-color-alt: windowtext; background: white;">doi: 10.1177/2192568217706367.</span></span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-color-alt: windowtext; background: white;">Groah, S., Schladen, M., Pineda, C., &amp; Hsieh, C. (2015).<span style="mso-spacerun: yes;"> </span>Prevention of pressure ulcers among people with spinal cord injury: A systematic review. *PM&amp;R: The Journal of injury, function, and rehabilitation, 7*(6), 613-636. doi: 10.1016/j.pmrj.2014.11.014</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">7.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Liu, Y., Xu, H., Liu, F., Lv, Z., Kan, S., Ning, G., &amp; Feng, S. (2017). Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.<span style="mso-spacerun: yes;"> </span>*International Journal of Surgery, 43,* 94-100. <span style="color: black; mso-color-alt: windowtext; background: white;">doi: 10.1016/j.ijsu.2017.05.066</span></span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">8.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-color-alt: windowtext; background: white;">Saadeh, Y., Smith, B., Joseph, J., Jaffer, S., Buckingham, M., Oppenlander, M., Szerlip, N., &amp; Park, P. (2017). The impact of blood pressure management after spinal cord injury: a systematic review of the literature. *Journal of Neurosurgery, 43*(5), 1-7. </span>[<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">https://doi.org/10.3171/2017.8.FOCUS17428</span>](https://doi.org/10.3171/2017.8.FOCUS17428)

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">9.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Sabit, B., Zeiler, F., &amp; Berrington, N. (2018). The impact of mean arterial pressure on functional outcome post trauma-related acute spinal cord injury: A scoping systematic review of human literature. *Journal of Intensive Care Medicine, 33*(1), 3-15. <span style="color: black; mso-color-alt: windowtext; background: white;">doi: 10.1177/0885066616672643.</span></span>

<span class="citation-doi"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">10.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Stein, D., &amp; Knight, W. (2017). Emergency neurological life support: Traumatic spine injury. *Neurocritical Care, 27,* 170-180. <span class="citation-doi">doi: 10.1007/s12028-017-0462-z.</span></span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">11.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span class="citation-doi"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Walters, B., Hadely, M., Hurlbert, R., Aarabi, B., Dhall, S., Gelb, D., Harrigan, M., Rozelle, C., Ryken, T., &amp; Theodore, N. (2013). Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. *Neurosurgery, 60*, 82-91. </span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; color: black; mso-color-alt: windowtext; background: white;">doi: 10.1227/01.neu.0000430319.32247.7f.</span>

<span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;"><span style="mso-list: Ignore;">12.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif;">Zakrasek, E., Nielson, J., Kosarchuk, J., Crew, J., Ferguson, A. &amp; McKenna, S. (2017). Pulmonary outcomes following specialized respiratory management for acute cervical spinal cord injury: a retrospective analysis. *Spinal Cord, 55*(6), 559-565. <span style="color: black; mso-color-alt: windowtext; background: white;">doi: 10.1038/sc.2017.10</span></span>